Inflammatory Bowel Disease - Testing for the Diagnosis and Management - (0121) — MM 0121 | CIGNA Coverage Update

Cigna modified MM 0121 for IBD testing, effective September 26, 2025. Here's what billing teams need to know about CPT 83993 and the updated criteria.

Cigna Healthcare updated its IBD testing coverage policy under MM 0121 (policy code mm_0121_coveragepositioncriteria_serological_testing_for_ibd), covering the diagnosis and management of inflammatory bowel disease. The change affects fecal calprotectin testing billed under CPT 83993, along with a broad set of ICD-10 Crohn's disease and ulcerative colitis diagnosis codes spanning K50.00–K51.919. If your practice sees IBD patients and you bill Cigna for serological or stool-based testing, review your documentation standards before September 26, 2025.

Quick-Reference Table

Cigna IBD Testing Coverage Policy: Coverage Criteria and Medical Necessity Requirements 2025

The Cigna IBD testing coverage policy under MM 0121 designates CPT 83993 (fecal calprotectin) as medically necessary when specific criteria are met. The key phrase in the policy is "medically necessary when criteria in the applicable coverage position are met." That's the gate your documentation has to clear.

Fecal calprotectin testing is a non-invasive stool marker used to distinguish IBD from irritable bowel syndrome (IBS). Cigna's inclusion of both IBD codes (K50.xx, K51.xx) and IBS codes (K58.0, K58.1) in the covered diagnosis list signals that the test is allowed in both confirmed IBD patients and in the differential diagnosis workup — when the clinical picture supports it. That distinction matters for your billing team.

Medical necessity for CPT 83993 requires clinical documentation that supports why the test was ordered. Think: active symptoms, monitoring disease activity, or distinguishing IBD from IBS. Vague documentation won't hold up if Cigna requests records on a claim denial.

Prior authorization requirements for IBD-related testing under MM 0121 are not explicitly stated as mandatory in the available policy data — but that doesn't mean your specific plan contracts don't require it. Check the member's plan before assuming PA is waived, especially for high-volume or repeat testing.

Reimbursement for CPT 83993 is contingent on diagnosis code alignment. A calprotectin test billed without a supported ICD-10 from the approved list — or with a code that doesn't match the documented clinical reason — will flag for review.

Cigna IBD Testing Exclusions and Non-Covered Indications

The policy data doesn't enumerate a separate "not covered" or "experimental" list for MM 0121 in the available summary. That's not a green light for blanket coverage. It means the coverage position hinges entirely on whether your CPT 83993 claim meets the medical necessity criteria and pairs with a supported diagnosis code.

If you're billing serological IBD panels — tests beyond fecal calprotectin — those are not covered under this single CPT-listed policy update. MM 0121 explicitly names one CPT code. Billing other IBD-related serological tests without confirmed Cigna coverage is a claim denial waiting to happen.

If your practice orders panels marketed as IBD diagnostic workups (common in DTC lab testing), confirm each component code has its own Cigna coverage position before billing. Don't assume MM 0121 covers the bundle.

Coverage Indications at a Glance

Cigna IBD Testing Billing Guidelines and Action Items 2025

CPT, HCPCS, and ICD-10 Codes for IBD Testing Under MM 0121

Covered CPT Codes (When Medical Necessity Criteria Are Met)

Key ICD-10-CM Diagnosis Codes

Note: The policy data references four additional ICD-10-CM codes beyond those listed above. Pull the full code list from the source policy at Cigna's provider portal or via the PayerPolicy source link to confirm all covered diagnosis codes before updating your charge capture.

One More Thing on MM 0121 Cigna System Billing

The real issue with this type of policy modification is what the summary doesn't spell out. The policy establishes CPT 83993 as covered under MM 0121 Cigna system criteria — but the medical necessity bar is enforced at the documentation level, not the code level. You can have the right code, the right diagnosis, and still get a denial if the clinical notes don't support why the test was ordered.

This is the same pattern you see with other Cigna lab policies. The code clears the technical edit. The documentation triggers the clinical review. Make sure your billing guidelines for CPT 83993 include a documentation checklist — not just a code crosswalk.